{
    "root": "29dd291f-caa8-4ac4-ab3d-d5769be390f2",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Arsenic trioxide",
    "value": "20250514",
    "ingredients": [
        {
            "name": "ARSENIC TRIOXIDE",
            "code": "S7V92P67HO"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "Arsenic trioxide injection is an arsenical indicated: In combination with tretinoin for treatment of adults with newly-diagnosed low-risk acute promyelocytic leukemia (APL) whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression. ( 1.1 ) For induction of remission and consolidation in patients with APL who are refractory to, or have relapsed from, retinoid and anthracycline chemotherapy, and whose APL is characterized by the presence of the t(15;17) translocation or PML/RAR-alpha gene expression. ( 1.2 )",
    "contraindications": "Newly-diagnosed low-risk APL: Induction: Administer 0.15 mg/kg/day intravenously daily in combination with tretinoin until bone marrow remission. Do not exceed 60 days. ( 2.1 ) Consolidation: Administer 0.15 mg/kg/day intravenously daily for 5 days per week during weeks 1-4 of each 8-week cycle for a total of 4 cycles in combination with tretinoin. ( 2.1 ) Relapsed or refractory APL: Induction: Administer 0.15 mg/kg/day intravenously daily until bone marrow remission. Do not exceed 60 days. ( 2.2 ) Consolidation: Administer 0.15 mg/kg/day intravenously daily for 25 doses over a period of up to 5 weeks. ( 2.2 )",
    "warningsAndPrecautions": "How Supplied\n                  \n                  Arsenic trioxide injection is supplied as a sterile, clear, colorless solution in 10 mL glass, single-dose vials.\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                               NDC\n                              \n                           \n                           \n                               Strength\n                              \n                           \n                           \n                               Pack Style\n                              \n                           \n                        \n                        \n                            70710-1896-6\n                           \n                            12 mg/6 mL (2 mg/mL) single-dose vials\n                           \n                            10 vials per carton\n                           \n                        \n                     \n                  \n                  \n                     Storage and Handling\n                  \n                  Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [See USP Controlled Room Temperature]. Do not freeze.\n                  Arsenic trioxide is a hazardous drug. Follow applicable special handling and disposal procedures.1",
    "adverseReactions": "Arsenic trioxide is contraindicated in patients with hypersensitivity to arsenic."
}